Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Fahrleitner-Pammer

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Wiener Medizinische Wochenschrift (1946)|August 18, 2010
Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?Doris Wagner, Astrid Fahrleitner-Pammer
Best Practice & Research. Clinical Rheumatology|September 26, 2022
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directionsHans P Dimai, Astrid Fahrleitner-Pammer
Wiener Medizinische Wochenschrift (1946)|August 27, 2011
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a reviewDaniela-Eugenia Malliga, Doris Wagner, Astrid Fahrleitner-Pammer
Disease Markers|October 23, 2015
FGF23 in Acute and Chronic IllnessChristian Schnedl, Astrid Fahrleitner-Pammer, Peter Pietschmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral densityChristian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, et al.
Cases Journal|February 26, 2010
Vitamin D deficiency following Billroth II surgery - How much vitamin D is enough?: a case reportEva Sampl, Doris Wagner, Claudia Friedl, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 21, 2018
Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White WomenBernhard Steiner, Hans Peter Dimai, Hubert Steiner, et al.
Wiener Medizinische Wochenschrift (1946)|June 13, 2012
Update on denosumab in postmenopausal osteoporosis--recent clinical dataChristian Muschitz, Astrid Fahrleitner-Pammer, Johannes Huber, et al.
Calcified Tissue International|March 12, 2020
Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical TrialPiet Geusens, David L Kendler, Astrid Fahrleitner-Pammer, et al.
Nutrients|June 27, 2024
Increased Early Postoperative Complication Rate after Osteoporotic Hip Fracture in Patients with Low 25 (OH) Vitamin D LevelsAndrea Fink, Paul Puchwein, Astrid Fahrleitner-Pammer, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Wiener Medizinische Wochenschrift (1946)|August 18, 2010
Levels of osteoprotegerin (OPG) and receptor activator for nuclear factor kappa B ligand (RANKL) in serum: are they of any help?Doris Wagner, Astrid Fahrleitner-Pammer
Best Practice & Research. Clinical Rheumatology|September 26, 2022
Osteoporosis and Fragility Fractures: currently available pharmacological options and future directionsHans P Dimai, Astrid Fahrleitner-Pammer
Wiener Medizinische Wochenschrift (1946)|August 27, 2011
The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a reviewDaniela-Eugenia Malliga, Doris Wagner, Astrid Fahrleitner-Pammer
Disease Markers|October 23, 2015
FGF23 in Acute and Chronic IllnessChristian Schnedl, Astrid Fahrleitner-Pammer, Peter Pietschmann, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 28, 2012
Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral densityChristian Muschitz, Roland Kocijan, Astrid Fahrleitner-Pammer, et al.
Cases Journal|February 26, 2010
Vitamin D deficiency following Billroth II surgery - How much vitamin D is enough?: a case reportEva Sampl, Doris Wagner, Claudia Friedl, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 21, 2018
Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White WomenBernhard Steiner, Hans Peter Dimai, Hubert Steiner, et al.
Wiener Medizinische Wochenschrift (1946)|June 13, 2012
Update on denosumab in postmenopausal osteoporosis--recent clinical dataChristian Muschitz, Astrid Fahrleitner-Pammer, Johannes Huber, et al.
Calcified Tissue International|March 12, 2020
Distribution of Prevalent and Incident Vertebral Fractures and Their Association with Bone Mineral Density in Postmenopausal Women in the Teriparatide Versus Risedronate VERO Clinical TrialPiet Geusens, David L Kendler, Astrid Fahrleitner-Pammer, et al.
Nutrients|June 27, 2024
Increased Early Postoperative Complication Rate after Osteoporotic Hip Fracture in Patients with Low 25 (OH) Vitamin D LevelsAndrea Fink, Paul Puchwein, Astrid Fahrleitner-Pammer, et al.
Pageof 10